Javelin Pharmaceuticals, Inc. (JAV)
$1.45
-0.01 (-0.68%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $1.46 |
| Daily Range | $1.43 - $1.50 |
| 52-Week Range | $0.40 - $2.28 |
| Market Cap | $92.6M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 119,137 |
| Average Daily Volume | 376,000 |
JAV
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
JAV Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
JAV News and Commentary
- 5-Star Stocks on the Upswing – The Motley Fool
- 5 Stocks Bucking the Downtrend – The Motley Fool
- Stock Ideas from ETF Innovators New Indexes – Blog at The Motley Fool
- A Rough Flight for Javelin Pharma – Blog at The Motley Fool
- 5 Stocks That Swayed the Skeptics – The Motley Fool
- Abraxis Tries On More Platform Shoes – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- 6 Stocks Under Attack – The Motley Fool
Related News and Articles
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool
- 52-Week Highs! What's Going On? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
RSS Headlines
Fool UK
